PR Newswire - Antengene Announces XPOVIO® (selinexor) Approved f...
XPOVIO® is the first and only approved XPO1 inhibitor in Malaysia. XPOVIO® has been approved for multiple indications in eight markets across the APAC region. Antengene h...
Read More

ภาษาไทย
English